0001624178-22-000002.txt : 20220913 0001624178-22-000002.hdr.sgml : 20220913 20220913133346 ACCESSION NUMBER: 0001624178-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220913 DATE AS OF CHANGE: 20220913 EFFECTIVENESS DATE: 20220913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurolens, Inc. CENTRAL INDEX KEY: 0001624178 IRS NUMBER: 455334353 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-458709 FILM NUMBER: 221240319 BUSINESS ADDRESS: STREET 1: 1234 LAKESHORE DRIVE #200 CITY: COPPELL STATE: TX ZIP: 75019 BUSINESS PHONE: 888-236-2219 MAIL ADDRESS: STREET 1: 1234 LAKESHORE DRIVE #200 CITY: COPPELL STATE: TX ZIP: 75019 FORMER COMPANY: FORMER CONFORMED NAME: eyeBrain Medical, Inc. DATE OF NAME CHANGE: 20141104 D 1 primary_doc.xml X0708 D LIVE 0001624178 Neurolens, Inc. 1234 LAKESHORE DRIVE #200 COPPELL TX TEXAS 75019 888-236-2219 DELAWARE eyeBrain Medical, Inc. Corporation true J. Andy Corley c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director Steve Kirby c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director Davis Corley c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Executive Officer Director Tom Finzi c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director William Link c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director Das Narayandas c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director Pierre Bertrand c/o Neurolens, inc. 1234 Lakeshore Drive. #200 Coppell TX TEXAS 75019 Executive Officer Danny Perales c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Executive Officer Akhilesh Pathipati c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director Eric Bednarski c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Director Aric Plumley c/o Neurolens, Inc. 1234 Lakeshore Drive #200 Coppell TX TEXAS 75019 Executive Officer Biotechnology Decline to Disclose 06b false 2022-09-01 false true false 0 67642795 67642795 0 Total amount sold includes $52,011,674.81 of new cash and $15,631,127.67 of conversion of debt. false 31 0 0 0 false Neurolens, Inc. /s/ Pierre Bertrand Pierre Bertrand CEO 2022-09-08